FOXO TECHNOLOGIES INC. Increase (Decrease) in Materials and Supplies
FOXO TECHNOLOGIES INC. (FOXO) reported Increase (Decrease) in Materials and Supplies of $1.84 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInMaterialsAndSupplies · last filed 2025-11-10
- FOXO TECHNOLOGIES INC. increase (decrease) in materials and supplies for the quarter ending 2025-09-30 was -$2.75K.
- FOXO TECHNOLOGIES INC. increase (decrease) in materials and supplies for the quarter ending 2025-06-30 was -$22.33K.
- FOXO TECHNOLOGIES INC. increase (decrease) in materials and supplies for the quarter ending 2025-03-31 was $26.92K.
- FOXO TECHNOLOGIES INC. increase (decrease) in materials and supplies for the quarter ending 2024-12-31 was -$48.06K.
- FOXO TECHNOLOGIES INC. increase (decrease) in materials and supplies for fiscal 2024 was -$40.27K.
- FOXO TECHNOLOGIES INC. increase (decrease) in materials and supplies for fiscal 2023 was -$1.31M, a 229.00% decline from fiscal 2022.
- FOXO TECHNOLOGIES INC. increase (decrease) in materials and supplies for fiscal 2022 was $1.02M, a 245.08% increase from fiscal 2021.
- FOXO TECHNOLOGIES INC. increase (decrease) in materials and supplies for fiscal 2021 was $295.00K.
| Period end | Increase (Decrease) in Materials and Supplies 3 month | Increase (Decrease) in Materials and Supplies 6 month | Increase (Decrease) in Materials and Supplies 9 month | Increase (Decrease) in Materials and Supplies 9 month as first filed | Increase (Decrease) in Materials and Supplies 12 month | Increase (Decrease) in Materials and Supplies 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-09-30 | -$2.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$25.08K derived: sum of 2 quarters · filed 2025-11-10 | $1.84K 10-Q · filed 2025-11-10 | -$46.23K derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2025-06-30 | -$22.33K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-08-19 | $4.59K 10-Q · filed 2025-08-19 | -$43.48K derived: sum of 3 quarters · filed 2025-08-19 | |||
| 2025-03-31 | $26.92K 10-Q/A · filed 2025-08-19 | -$21.14K derived: sum of 2 quarters · filed 2025-08-19 | ||||
| 2024-12-31 | -$48.06K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$40.27K 10-K · filed 2025-04-15 | ||||
| 2024-09-30 | $7.80K 10-Q · filed 2025-11-10 | $8.00K 10-Q · filed 2024-11-19 | ||||
| 2023-12-31 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$1.30M derived: sum of 2 quarters · filed 2025-04-15 | -$1.30M derived: sum of 3 quarters · filed 2025-04-15 | -$1.31M 10-K · filed 2025-04-15 | -$1.31M 10-K · filed 2024-06-06 | |
| 2023-09-30 | -$171.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | -$171.00K derived: sum of 2 quarters · filed 2024-11-19 | -$182.00K 10-Q · filed 2024-11-19 | -$926.00K derived: sum of 4 quarters · filed 2024-11-19 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | -$11.00K 10-Q · filed 2024-08-19 | -$755.00K derived: sum of 3 quarters · filed 2024-08-19 | $104.00K derived: sum of 4 quarters · filed 2024-08-19 | ||
| 2023-03-31 | -$11.00K 10-Q · filed 2024-06-28 | -$755.00K derived: sum of 2 quarters · filed 2024-06-28 | $104.00K derived: sum of 3 quarters · filed 2024-06-28 | $1.06M derived: sum of 4 quarters · filed 2024-06-28 | ||
| 2022-12-31 | -$744.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | $115.00K derived: sum of 2 quarters · filed 2024-06-06 | $1.07M derived: sum of 3 quarters · filed 2024-06-06 | $1.02M 10-K · filed 2024-06-06 | ||
| 2022-09-30 | $859.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-06-04 | $1.82M derived: sum of 2 quarters · filed 2024-06-04 | $1.76M 10-Q/A · filed 2024-06-04 | $1.76M derived: sum of 4 quarters · filed 2024-06-04 | ||
| 2022-06-30 | $960.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $903.00K 10-Q · filed 2023-08-10 | $902.00K derived: sum of 3 quarters · filed 2023-08-10 | |||
| 2022-03-31 | -$57.00K 10-Q · filed 2023-05-11 | -$58.00K derived: sum of 2 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $295.00K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $296.00K 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |